Kumaree KK, Prasanth MI, Sivamaruthi BS, Kesika P, Tencomnao T, Chaiyasut C, Prasansuklab A (2023) Lactobacillus paracasei HII01 enhances lifespan and promotes neuroprotection in Caenorhabditis elegans
This formula follows the same dual-pathway mechanism used in leading, FDA-approved incretin therapies
& Henry, C
Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, et al
For 503A pharmacies, FDA reiterated a limited enforcement policy from its 2018 guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: the agency does not intend to take action where a compounder fills four or fewer prescriptions per calendar month of a drug that is essentially a copy of a commercially available drug
More than medication You are not just getting medication